Live feed
Filing
SC 13G
SC 13G0001104659-15-018989·CAPITAL VENTURES INTERNATIONAL
Schedule 13G ownership disclosure
Cyclacel Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 23254L306
Event date: 2015-03-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,026,260
- Percent of class
- 8.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-15-018989
- Form type
- SC 13G
- Filer
- CAPITAL VENTURES INTERNATIONAL
- CIK
- CIK 1011712
- Filed
- Mar 12, 2015
- Reporting period
- Mar 03, 2015
- Description
- Schedule 13G beneficial ownership